These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19426157)

  • 1. High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis.
    Nathalie HV; Chris P; Serge G; Catherine C; Benjamin B; Claire B; Christelle P; Briollais L; Pascale R; Marie-Lise J; Yves C
    J Cell Mol Med; 2009 Sep; 13(9B):4014-22. PubMed ID: 19426157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
    Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
    Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer.
    Nagahara H; Mimori K; Utsunomiya T; Barnard GF; Ohira M; Hirakawa K; Mori M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6800-6. PubMed ID: 16203767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and survival of lung cancer cells: regulation by kallikrein-related peptidase 6 via activation of proteinase-activated receptor 2 and the epidermal growth factor receptor.
    Michel N; Heuzé-Vourc'h N; Lavergne E; Parent C; Jourdan ML; Vallet A; Iochmann S; Musso O; Reverdiau P; Courty Y
    Biol Chem; 2014 Sep; 395(9):1015-25. PubMed ID: 24643912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
    Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
    Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner.
    Bae KM; Wang H; Jiang G; Chen MG; Lu L; Xiao L
    Cancer Res; 2007 Jul; 67(13):6053-63. PubMed ID: 17616661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.
    Sells E; Pandey R; Chen H; Skovan BA; Cui H; Ignatenko NA
    Neoplasia; 2017 May; 19(5):396-411. PubMed ID: 28431272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients.
    Haritos C; Michaelidou K; Mavridis K; Missitzis I; Ardavanis A; Griniatsos J; Scorilas A
    Clin Exp Med; 2018 May; 18(2):203-213. PubMed ID: 29435805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc-mediated upregulation of NAT10 facilitates tumor development via cell cycle regulation in non-small cell lung cancer.
    Wang Z; Huang Y; Lu W; Liu J; Li X; Zhu S; Liu H; Song Y
    Med Oncol; 2022 Jul; 39(10):140. PubMed ID: 35834140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of LINC01510 predicts poor prognosis and promotes malignant progression in human non-small cell lung cancer.
    Li J; Wei L
    Biomed Pharmacother; 2019 Jan; 109():519-529. PubMed ID: 30399588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expressions of STAT3, WWOX and c-myc in human non small cell lung cancer tissue and correlativity analysis].
    Hu FY; Wang LP; Hou LL; Yin G; Wang HC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Dec; 26(12):1203-5, 1209. PubMed ID: 21138684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
    Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
    Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
    Wang Y; Zhou Y; Tao F; Chai S; Xu X; Yang Y; Yang Y; Xu H; Wang K
    Cancer Lett; 2017 Aug; 401():53-62. PubMed ID: 28456659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALKBH4 promotes tumourigenesis with a poor prognosis in non-small-cell lung cancer.
    Jingushi K; Aoki M; Ueda K; Kogaki T; Tanimoto M; Monoe Y; Ando M; Matsumoto T; Minami K; Ueda Y; Kitae K; Hase H; Nagata T; Harada-Takeda A; Yamamoto M; Kawahara K; Tabata K; Furukawa T; Sato M; Tsujikawa K
    Sci Rep; 2021 Apr; 11(1):8677. PubMed ID: 33883577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
    Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer.
    Dworakowska D; Jassem E; Jassem J; Karmoliński A; Lapiński M; Tomaszewski D; Rzyman W; Jaśkiewicz K; Sworczak K; Grossman AB
    Lung Cancer; 2009 Oct; 66(1):127-33. PubMed ID: 19200616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic expression of KLK6 in MDA-MB-435 melanoma cells reduces tumorigenicity in vivo.
    Pampalakis G; Zingkou E; Zoumpourlis V; Sotiropoulou G
    Pathol Res Pract; 2021 Jan; 217():153276. PubMed ID: 33249398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
    White NM; Mathews M; Yousef GM; Prizada A; Popadiuk C; Doré JJ
    Br J Cancer; 2009 Oct; 101(7):1107-13. PubMed ID: 19707197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
    Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
    Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.